47 results
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... for each of the components ... of the algorithm ... CRP < 20 mg/L #Diagnosis ... Management #Pediatrics #Peds
PEMSource: Algorithm for fever WITHOUT source by Age
#Diagnosis #Management #Peds #Fever #Without #Source #Table #Algorithm #PEMSource
PEMSource: Algorithm ... for fever WITHOUT ... source by Age #Diagnosis ... #Management #Peds ... #Source #Table
Validation of the Step-By-Step Approach to Febrile Infants

#Diagnosis #Management #Pediatrics #Peds #Febrile #Infant #StepByStep #Algorithm #LP
Febrile Infants #Diagnosis ... Management #Pediatrics #Peds ... Infant #StepByStep #Algorithm ... #Antibiotics #Risk ... Stratification #Fever
Pediatric UTI Algorithm (2-24 months of age)

Risk stratify with UTI Calc: 
 - Age months
Pediatric UTI Algorithm ... months of age) Risk ... - No other fever ... #Diagnosis #Management ... UrinaryTractInfection #Peds
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Management of Fever ... Neutropenia LOW RISK ... stable and no medical ... #IDSA #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Key Components: ... or family - Ever ... event, follow ACC algorithm ... Change in clinical ... stratification #diagnosis
Comparison of Fever Algorithms for Infants <3 months old

AGE, INCLUSION, TESTS 
REQUIRED, "LOW RISK" CRITERIA, TREATMENT,
Comparison of Fever ... Algorithms for ... REQUIRED, "LOW RISK ... " CRITERIA, TREATMENT ... #Table #Performance
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
factors: Critical ... : 33% • Treatment ... : No • Treatment ... Reactions #hematology #diagnosis ... #comparison #table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... , may consider risks ... highlighted circle= clinical ... trial Ever Arias ... #Pharmacology #Table
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
yield of available diagnostic ... presence of patient risk ... lung malignancy, clinical ... The treatment of ... with a higher risk